The effect of typical and atypical antipsychotic drugs on sleep of schizophrenic patients

Serotonin and Sleep: Molecular, Functional and Clinical Aspects

Volumn , Issue , 2008, Pages 587-610

  Winokur, Andrew ^a   Kamath, Jayesh ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882755511     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7643-8561-3_24     Document Type: Chapter

References (57)

1. Winokur A (1998) Sleep disorders. In: SJ Enna, JT Coyle (eds): Pharmacological management of neurological and psychiatric disorders. McGraw-Hill, New York, 213-235
2. Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric disorders: A meta-analysis. Arch Gen Psychiatry 49: 651-668
3. Bensen KL (2006) Sleep in Schizophrenia: impairments, correlates and treatments. Psychiatr Clin N Am 29: 1033-1045
4. Monti JM, Monti D (2002) Sleep in schizophrenic patients and the effects of antipsychotic drugs. Sleep Med Rev 8: 133-148
5. Monti JM, Monti D (2000) Sleep in generalized anxiety disorder and its treatment. Sleep Med Rev 4: 263-276
6. Bauer M, Grof P, Rasgon N, Bschor T, Glenn T, Whybrow PC (2006) Temporal relation between sleep and mood in patients with bipolar disorder. Bipolar Disord 8: 160-167
7. Armitage R (2007) Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand 115 (Suppl 433): 194-115
8. Ritsner M, Kurs R, Ponizovsky A, Hadjez J (2004) Perceived quality of life in schizophrenia: relationships to sleep quality. Qual Life Res 13: 783-791
9. Monti JM, Monti D (2005) Sleep disturbance in schizophrenia. Int Rev Psychiatry 17: 247-253
10. Keshavan MS, Reynolds CF, Kupfer DJ (1990) Electroencephalographic sleep in schizophrenia: A critical review. Compr Psychiatry 30: 34-47
11. Keshavan MS, Reynolds CF, Miewald JM, Montrose DM, Sweeney JA, Vasko RC, Kupfer DJ (1998) Delta sleep deficits in schizophrenia: Evidence from automated analyses of sleep data. Arch Gen Psychiatry 55: 443-448
12. Hiatt JF, Floyd TC, Katz PH, Feinberg I (1985) Further evidence of abnormal nonrapid-eye-movement sleep in schizophrenia. Arch Gen Psychiatry 42: 797-802
13. Ferrarelli F, Huber R, Peterson MJ, Massimini M, Murphy M, Riedner BA, Watson A, Bria P, Tononi G (2007) Reduced sleep spindle activity in schizophrenia patients. Am J Psychiatry 164: 483-492
14. Jones BE (2005) Basic mechanisms of sleep-wake states. In: Kryger MH, Roth T, Dement W (eds.) Principles and Practice of Sleep Medicine, 4th edn. Elsevier, Amsterdam, 136-153
15. Hajak G, Geisler P (2003) Orchestrating sleep-wake functions in the brain. Nat Med 9: 170-171
16. Mendelson WB (2001) Neurotransmitters and sleep. J Clin Psychiatry 62 (Suppl 10): 5-8
17. Siegel JM (2004) The neurotransmitters of sleep. J Clin Psychiatry 65 (Suppl 16): 4-7
18. Pace-Schott EF, Hobson JA (2002) The neurobiology of sleep: Genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3: 591-605
19. Soldatos CR, Paparrigopoulis TJ (2005) Sleep physiology and pathology: Pertinence to psychiatry. Int Rev Psychiatry 17: 213-228
20. Richelson E (1999) Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 60 (Suppl 10): 5-14
21. Reynolds GF (2004) Receptor mechanisms in the treatment of schizophrenia. J Psychopharmacol 18: 340-345
22. Kaplan J, Dawson S, Vaughan T, Green R, Wyatt RJ (1974) Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics. Arch Gen Psychiatry 31: 62-66
23. Taylor SF, Tandon R, Shipley JE, Eiser AS (1991) Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry 30: 904-912
24. Nofzinger EA, van Kammen DP, Gilbertson MW, Gurklis JA, Peters JL (1993) Electroencephalographic sleep in clinically stable schizophrenic patients: two-weeks versus six-weeks neuroleptic free. Biol Psychiatry 33: 829-835
25. Keshavan MS, Reynolds CF, Miewald JM, Montrose DM (1996) A longitudinal study of EEG sleep in schizophrenia. Psychiatry Res 59: 203-211
26. Maixner S, Tandon R, Eiser A, Taylor S, DeQuardo JR, Shipley J (1998) Effects of antipsychotic treatment on polysomnographic measures of schizophrenia: A replication and extension. Am J Psychiatry 155: 1600-1602
27. Wetter TC, Lauer CJ, Gillich G, Pollmacher T (1996) The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J Psychiatr Res 30: 411-419
28. Yamashita H, Morinobu S, Yamakawi S, Horiguchi J, Nagao M (2002) Effect of risperidone on sleep in schizophrenia: A comparison with haloperidol. Psychiatry Res 109: 137-142
29. Hinze-Selch D, Mullington J, Orth A, Lauer CJ, Pollmacher T (1997) Effects of clozapine on sleep: A longitudinal study. Biol Psychiatry 42: 260-266
30. Touyz SW, Beumont PJ, Saayman GS, Zabow T (1977) A psychophysiological investigation of the short-term effect of clozapine upon sleep parameters in normal young adults. Biol Psychiatry 12: 801-822
31. Lee JH, Woo JI, Meltzer HY (2001) Effects of clozapine on sleep measures and sleepassociated changes in growth hormone and cortisol in patients with schizophrenia. Psychiatry Res 103: 157-166
32. Armitage R, Cole D, Suppes T, Ozcan M (2004) Effects of clozapine on sleep in bipolar and schizoaffective disorders. Prog Neuropsychopharmacol Biol Psychiatry 28: 1065-1070
33. Fadre L, Nyberg S, Oxenstierna G, Nakashima Y, Halldin C, Ericsson B (1995) Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidonetreated schizophrenic patients. J Clin Psychopharmacol 15 (Suppl 1): 19S-23S
34. Dursun SM, Patel JKM, Burke JG, Reveley MA (1999) Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: A pilot study. J Psychiatry Neurosci 24: 333-337
35. Haffmans PMJ, Oolders JM, Hoencamp E, Arends JBAM (2001) The effect of risperidone versus haloperidol on sleep patterns of schizophrenic patients: results of a double-blind, randomized pilot trial. Eur Neuropsychopharm 11(Suppl. 3): S260
36. Sharpley AL, Bhagwagar Z, Hafizi S, Whale WR, Gijsman HJ, Cowen PJ (2003) Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients. J Clin Psychiatry 64: 192-196
37. Bymaster FP, Calligaro DO, Falcone JF, March RD, Moore NA, Tye C, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14: 87-96
38. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Laurrabaquio MR (1999) Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry 46: 141-143
39. Sharpley AL, Vassallo CM, Cowen PJ (2000) Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT2C receptors in vivo. Biol Psychiatry 47: 468-470
40. Sharpley AL, Vassallo CM, Pooley EC, Harrison PJ, Cowen PJ (2001) Allelic variation in the 5-HT2C receptor and the increase in slow wave sleep produced by olanzapine. Psychopharmacology 153: 271-272
41. Muller MJ, Rossbach W, Mann K, Roschke J, Muller-Siecheneder F, Blumler M, Wetzel H, Rub H, Dittmann RW, Benkert O (2004) Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms. Pharmacopsychiatry 37: 157-162
42. Markowitz JS, Brown CS, Moore TR (1999) Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother 33: 73-85
43. Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W, Meier A, Ruther E (2004) Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology 174: 421-429
44. Sokolski KN, Brown BJ (2006) Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine. Ann Pharmacother 40: 567-570
45. Fernando A, Chew G (2005) Chronic insomnia secondary to refractory chronic pain responding to quetiapine. Intern Med J 35: A25
46. Robert S, Hamner MB, Kose S, Ulmer HG, Deitsch SE, Loberbaum JP (2005) Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective open-label study. J Clin Psychopharmacol 25: 387-388
47. Stahl SM, Shayegan DK (2003) The psychopharmacology of ziprasidone: receptorbinding properties and real-world psychiatric practice. J Clin Psychiatry 64 (Suppl 19): 6-12
48. Cohrs S, Meier A, Neumann A-C, Jordan W, Ruther E, Rodenbeck A (2005) Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: A randomized, controlled crossover trial of 12 healthy male subjects. J Clin Psychiatry 66: 989-996
49. DeMartinis NA, Winokur A (2006) Effects of psychiatric medications on sleep and sleep disorders. CNS Neurol Disord Drug Targets 4: 17-29
50. Wilson SJ, Bailey JE, Rich AS, Nash J, Adrover M, Tournoux A, Nutt DJ (2005) The use of sleep measures to compare a new 5-HT1A agonist with buspirone in humans. J Psychopharmacol 19: 609-613
51. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302: 381-389
52. Grunder G, Kungel M, Ebrecht M, Gorocs T, Modell S (2006) Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia. Pharmacopsychiatry
53. (Suppl 1): S21-S25
54. Berman RM, Marcus RN, Swanink R, Carson WH, McQuade RD, Khan A (2007) Efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study (Study CN138-139). Presented at the 160th American Psychiatric Association Annual Meeting, San Diego, CA
55. Schotte A, Janssen PFM, Gommerenk W, Luyten WHML, Van Gompel P, Lesage AS, De Loore K, Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124: 57-73
56. Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, Cleton A, Eerdekens M, Battisti WP, Palumbo JM (2007) A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol 22: 299-308
57. Yamashita H, Mori K, Nagao M, Okammoto Y, Morinobu S, Yamawaki S (2004) Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population. J Clin Psychiatry 65: 1525-1530